Any level of random sampling is a serious concern for a conglomerate like P&G with both many products and high volume. Negasmart may be able to sell for years at a substantial volume for them, at a considerably higher price compared to BRICS, before their first finding. I would like to see evidence from the FDA that they aren't just lucky on this one detection, (if it even was detected by them before doctors/parents reports.)